J A Galanko
Overview
Explore the profile of J A Galanko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
274
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease
Dassopoulos T, Dubinsky M, Bentsen J, Martin C, Galanko J, Seidman E, et al.
Aliment Pharmacol Ther
. 2013 Nov;
39(2):163-75.
PMID: 24237037
Background: Azathioprine (AZA), a pro-drug metabolised to the active metabolites 6-tioguanine nucleotides (6TGN), is a steroid-sparing therapy for Crohn's disease (CD). Aim: To investigate whether AZA therapy is optimised by...
2.
Shaheen N, Crockett S, Bright S, Madanick R, Buckmire R, Couch M, et al.
Aliment Pharmacol Ther
. 2010 Nov;
33(2):225-34.
PMID: 21083673
Background: Cough may be a manifestation of gastro-oesophageal reflux disease (GERD). The utility of acid suppression in GERD-related cough is uncertain. Aim: To assess the impact of high-dose acid suppression...
3.
Shaheen N, Peery A, Hawes R, Rothstein R, Spechler S, Galanko J, et al.
Endoscopy
. 2010 Oct;
42(10):790-9.
PMID: 20886398
Background And Study Aims: The impact of the diagnosis and treatment of dysplastic Barrett's esophagus on quality of life (QoL) is poorly understood. This study assessed the influence of dysplastic...
4.
Evon D, Verma A, Simpson K, Galanko J, Dougherty K, Fried M
Aliment Pharmacol Ther
. 2008 Feb;
27(11):1071-80.
PMID: 18266996
Background: Most research on the psychiatric symptoms of peginterferon/ribavirin for the treatment of hepatitis C comes from VA centres and clinical trials with rigid entry criteria that often excluded patients...
5.
Dellon E, Galanko J, Medapalli R, Russo M
Am J Transplant
. 2006 Jul;
6(9):2183-90.
PMID: 16827789
Because creatinine is heavily weighed in the MELD (model for end-stage liver disease) score, we sought to determine the impact of MELD-based organ allocation on outcomes after transplantation in the...
6.
Morton J, Galanko J, Soper N, Low D, Hunter J, Traverso L
Surg Endosc
. 2006 May;
20(7):1124-8.
PMID: 16703443
Background: Surgical outcomes are increasingly examined in an effort to improve quality and reduce medical error. The Nationwide Inpatient Sample (NIS) is a retrospective, claims-derived and population-based database and the...
7.
Walton K, Galanko J, Sartor R, Fisher N
Clin Exp Immunol
. 2006 Feb;
143(3):503-12.
PMID: 16487250
Commensal enteric bacteria stimulate innate immune cells and increase numbers of lamina propria and mesenteric lymph node (MLN) T and B lymphocytes. However, the influence of luminal bacteria on acquired...
8.
OMalley M, Shaheen N, Crosby M, Murray S, Klenzak J, Galanko J, et al.
N C Med J
. 2001 Sep;
62(5):292-7.
PMID: 11570329
No abstract available.
9.
BECKER R, Wu G, Galanko J, Chen W, Maynor A, Bose C, et al.
J Pediatr
. 2000 Dec;
137(6):785-93.
PMID: 11113834
Objective: To determine whether premature infants who have necrotizing enterocolitis (NEC) have deficiencies in glutamine (GLN) and arginine (ARG), which are essential to intestinal integrity. Study Design: A 4-month prospective...
10.
Shaheen N, Crosby M, OMalley M, Murray S, Sandler R, Galanko J, et al.
Am J Gastroenterol
. 2000 Nov;
95(11):3259-65.
PMID: 11095351
Objectives: Although nurse practitioners and physician assistants form a large and growing portion of the primary care workforce, little is known about their colorectal cancer screening practices. The aim of...